Last reviewed · How we verify
Rubus occidentalis extract
Rubus occidentalis extract is a Botanical extract / Nutraceutical Small molecule drug developed by Korea University Anam Hospital. It is currently FDA-approved for Health maintenance and antioxidant support (marketed).
Rubus occidentalis (black raspberry) extract contains polyphenols and anthocyanins that exert antioxidant and anti-inflammatory effects to support cellular health.
Rubus occidentalis extract is being studied in clinical trials for various skin conditions, including acne, eczema, skin aging, and cervical intraepithelial neoplasia. According to ChEMBL, Rubus occidentalis extract is a blocker of the voltage-sensitive sodium channel alpha-subunit, which is a specific molecular target.
At a glance
| Generic name | Rubus occidentalis extract |
|---|---|
| Sponsor | Korea University Anam Hospital |
| Drug class | Botanical extract / Nutraceutical |
| Modality | Small molecule |
| Therapeutic area | Preventive health / Oncology (investigational) |
| Phase | FDA-approved |
Mechanism of action
Black raspberry extract is rich in bioactive compounds including ellagic acid, anthocyanins, and other polyphenols that scavenge free radicals and reduce oxidative stress. These compounds may modulate inflammatory pathways and support immune function through their antioxidant properties. The extract has been studied for potential chemopreventive and health-promoting effects in various disease states.
Approved indications
- Health maintenance and antioxidant support (marketed)
Common side effects
Key clinical trials
- An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes (NA)
- A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization (PHASE2)
- Postprandial Glycemic Response to Polyphenol-fortified Snack Bars (NA)
- Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rubus occidentalis extract CI brief — competitive landscape report
- Rubus occidentalis extract updates RSS · CI watch RSS
- Korea University Anam Hospital portfolio CI
Frequently asked questions about Rubus occidentalis extract
What is Rubus occidentalis extract?
How does Rubus occidentalis extract work?
What is Rubus occidentalis extract used for?
Who makes Rubus occidentalis extract?
What drug class is Rubus occidentalis extract in?
What development phase is Rubus occidentalis extract in?
Related
- Drug class: All Botanical extract / Nutraceutical drugs
- Manufacturer: Korea University Anam Hospital — full pipeline
- Therapeutic area: All drugs in Preventive health / Oncology (investigational)
- Indication: Drugs for Health maintenance and antioxidant support (marketed)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing